1. Bergenin Reduces Experimental Painful Diabetic Neuropathy by Restoring Redox and Immune Homeostasis in the Nervous System
   Cristiane F. Villarreal et al, 2020, IJMS CrossRef
2. (+)-Usnic acid modulates the Nrf2-ARE pathway in FaDu hypopharyngeal carcinoma cells
   Violetta Krajka-Kuźniak et al, 2021, Mol Cell Biochem CrossRef
3. Genomic and Transcriptome Analysis to Identify the Role of the mTOR Pathway in Kidney Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance
   Xiangyu Che et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
4. A Fresh Look on Bergenin: Vision of Its Novel Drug Delivery Systems and Pharmacological Activities
   Sidharth Mehta et al, 2022, Future Pharmacology CrossRef
5. Research Progress on the Effect and Mechanism of Bergenin
   晓晓 蔚, 2022, PI CrossRef
6. Bergenin - A Biologically Active Scaffold: Nanotechnological Perspectives
   Reecha Madaan et al, 2022, CTMC CrossRef
7. Clinical Potential of Himalayan Herb Bergenia ligulata: An Evidence-Based Study
   Shubhadeep Roychoudhury et al, 2022, Molecules CrossRef
8. A SYSTEMATIC REVIEW ON CHEMICAL AND PHARMACOLOGICAL ACTIVITIES OF EXCOECARIA AGALLOCHA: A POTENTIAL SUNDARBAN PLANT
   Shaikh Jamal Uddin et al, 2023, Khulna Univ. Stud. CrossRef
9. Biosynthetic pathway of prescription bergenin from Bergenia purpurascens and Ardisia japonica
   Xiang-Yu Liu et al, 2024, Front. Plant Sci. CrossRef
10. Bergenia ciliata—Phytochemistry and Pharmacology: A Review
    Nikhil Kushwaha et al, 2024, Biomedical Materials & Devices CrossRef
11. A comprehensive review on the potential of coumarin and related derivatives as multi-target therapeutic agents in the management of gynecological cancers
    Gökçe Şeker Karatoprak et al, 2024, Front. Pharmacol. CrossRef
12. Bergenin, a bioactive flavonoid: advancements in the prospects of anticancer mechanism, pharmacokinetics and nanoformulations
    Pratibha Pandey et al, 2025, Front. Pharmacol. CrossRef